Investor Information
Latest News
-
Q1 2020 Indivior Financial Results Press Release
May 14, 2020 | PDF Version
-
Indivior receives approval for SUBUTEX® prolonged release solution for injection, 100mg and 300mg for substitution treatment of opioid dependence in Sweden
May 6, 2020 | PDF Version
-
Directorate Change
April 27, 2020 | PDF Version
-
Indivior to Announce Q1 2020 Results - May 14th
April 20, 2020 | PDF Version
Our Commitment
Updates on the Department of Justice Action
Get updates and information on Indivior’s ongoing response to the recent action by the U.S. Department of Justice and learn about the company’s unwavering commitment to patients, doctors, and communities fighting opioid addiction.
See more >
Upcoming Events
-
Jefferies Virtual Healthcare Conference 2020
June 2nd 2020
See more
Webcasts/Audiocasts/Presentations
Click on the headings to view online or download a presentation:
RNS Filings
View Indivior filings with the Regulatory News Service on regulatory and non-regulatory updates.
